201 related articles for article (PubMed ID: 31651842)
1. Steroid therapy and outcome of parapneumonic pleural effusions (STOPPE): Study protocol for a multicenter, double-blinded, placebo-controlled randomized clinical trial.
Fitzgerald DB; Waterer GW; Read CA; Fysh ET; Shrestha R; Stanley C; Muruganandan S; Lan NSH; Popowicz ND; Peddle-McIntyre CJ; Rahman NM; Gan SK; Murray K; Lee YCG
Medicine (Baltimore); 2019 Oct; 98(43):e17397. PubMed ID: 31651842
[TBL] [Abstract][Full Text] [Related]
2. Steroid Therapy and Outcome of Parapneumonic Pleural Effusions (STOPPE): A Pilot Randomized Clinical Trial.
Fitzgerald DB; Waterer GW; Budgeon C; Shrestha R; Fysh ET; Muruganandan S; Stanley C; Saghaie T; Badiei A; Sidhu C; Harryanto H; Duong V; Azzopardi M; Manners D; Lan NSH; Popowicz ND; Peddle-McIntyre CJ; Rahman NM; Read CA; Tan AL; Gan SK; Murray K; Lee YCG
Am J Respir Crit Care Med; 2022 May; 205(9):1093-1101. PubMed ID: 35081010
[No Abstract] [Full Text] [Related]
3. Dexamethasone for Parapneumonic Pleural Effusion: A Randomized, Double-Blind, Clinical Trial.
Tagarro A; Otheo E; Baquero-Artigao F; Navarro ML; Velasco R; Ruiz M; Penín M; Moreno D; Rojo P; Madero R;
J Pediatr; 2017 Jun; 185():117-123.e6. PubMed ID: 28363363
[TBL] [Abstract][Full Text] [Related]
4. Medical treatment of pleural infection: antibiotic duration and corticosteroid usefulness.
Skouras V; Chatzivasiloglou F; Iliopoulou M; Rimpa T
Breathe (Sheff); 2023 Dec; 19(4):230134. PubMed ID: 38125804
[TBL] [Abstract][Full Text] [Related]
5. Intra-pleural fibrinolytic therapy versus placebo, or a different fibrinolytic agent, in the treatment of adult parapneumonic effusions and empyema.
Altmann ES; Crossingham I; Wilson S; Davies HR
Cochrane Database Syst Rev; 2019 Oct; 2019(10):. PubMed ID: 31684683
[TBL] [Abstract][Full Text] [Related]
6. Comparative analysis of chest tube thoracostomy and video-assisted thoracoscopic surgery in empyema and parapneumonic effusion associated with pneumonia in children.
Aziz A; Healey JM; Qureshi F; Kane TD; Kurland G; Green M; Hackam DJ
Surg Infect (Larchmt); 2008 Jun; 9(3):317-23. PubMed ID: 18570573
[TBL] [Abstract][Full Text] [Related]
7. Parapneumonic effusions and empyema.
Light RW
Clin Chest Med; 1985 Mar; 6(1):55-62. PubMed ID: 3847302
[TBL] [Abstract][Full Text] [Related]
8. The significance of parapneumonic pleural effusions developing during antibiotic treatment for pneumonia.
Macrea M; Metersky ML
Conn Med; 2006; 70(6):371-5. PubMed ID: 16869468
[TBL] [Abstract][Full Text] [Related]
9. Update on the role of intrapleural fibrinolytic therapy in the management of complicated parapneumonic effusions and empyema.
Singh G; Pitoyo CW; Nasir AU; Rumende CM; Amin Z
Acta Med Indones; 2012 Jul; 44(3):258-64. PubMed ID: 22983084
[TBL] [Abstract][Full Text] [Related]
10. Implications of early sonographic evaluation of parapneumonic effusions in children with pneumonia.
Ramnath RR; Heller RM; Ben-Ami T; Miller MA; Campbell P; Neblett WW; Holcomb GW; Hernanz-Schulman M
Pediatrics; 1998 Jan; 101(1 Pt 1):68-71. PubMed ID: 9417153
[TBL] [Abstract][Full Text] [Related]
11. CT appearance of parapneumonic effusions in children: findings are not specific for empyema.
Donnelly LF; Klosterman LA
AJR Am J Roentgenol; 1997 Jul; 169(1):179-82. PubMed ID: 9207521
[TBL] [Abstract][Full Text] [Related]
12. Intrapleural urokinase versus normal saline in the treatment of complicated parapneumonic effusions and empyema. A randomized, double-blind study.
Bouros D; Schiza S; Tzanakis N; Chalkiadakis G; Drositis J; Siafakas N
Am J Respir Crit Care Med; 1999 Jan; 159(1):37-42. PubMed ID: 9872815
[TBL] [Abstract][Full Text] [Related]
13. Safety and Efficacy of Imatinib for Hospitalized Adults with COVID-19: A structured summary of a study protocol for a randomised controlled trial.
Emadi A; Chua JV; Talwani R; Bentzen SM; Baddley J
Trials; 2020 Oct; 21(1):897. PubMed ID: 33115543
[TBL] [Abstract][Full Text] [Related]
14. Intra-pleural fibrinolytic therapy versus conservative management in the treatment of adult parapneumonic effusions and empyema.
Cameron R; Davies HR
Cochrane Database Syst Rev; 2008 Apr; (2):CD002312. PubMed ID: 18425881
[TBL] [Abstract][Full Text] [Related]
15. [Using of fibrinolytics in the treatment of complicated parapneumonic effusion and empyema in children].
Uyan AP; Ozyürek H; Yilmaz E
Tuberk Toraks; 2003; 51(3):320-4. PubMed ID: 15143413
[TBL] [Abstract][Full Text] [Related]
16. A double blind randomized cross over trial comparing rate of decortication and efficacy of intrapleural instillation of alteplase vs placebo in patients with empyemas and complicated parapneumonic effusions.
Thommi G; Shehan JC; Robison KL; Christensen M; Backemeyer LA; McLeay MT
Respir Med; 2012 May; 106(5):716-23. PubMed ID: 22398159
[TBL] [Abstract][Full Text] [Related]
17. Surgical versus non-surgical management for pleural empyema.
Redden MD; Chin TY; van Driel ML
Cochrane Database Syst Rev; 2017 Mar; 3(3):CD010651. PubMed ID: 28304084
[TBL] [Abstract][Full Text] [Related]
18. Predicting Complicated Parapneumonic Effusion in Community Acquired Pneumonia: Hospital Based Case-Control Study.
P M; Awasthi S
Indian J Pediatr; 2019 Feb; 86(2):140-147. PubMed ID: 30182278
[TBL] [Abstract][Full Text] [Related]
19. Pleural Fluid suPAR Levels Predict the Need for Invasive Management in Parapneumonic Effusions.
Arnold DT; Hamilton FW; Elvers KT; Frankland SW; Zahan-Evans N; Patole S; Medford A; Bhatnagar R; Maskell NA
Am J Respir Crit Care Med; 2020 Jun; 201(12):1545-1553. PubMed ID: 32069085
[No Abstract] [Full Text] [Related]
20. Corticosteroid treatment for community-acquired pneumonia--the STEP trial: study protocol for a randomized controlled trial.
Blum CA; Nigro N; Winzeler B; Suter-Widmer I; Schuetz P; Briel M; Bingisser R; Zimmerli W; Ullmer E; Elsaesser H; Tarr P; Wirz S; Thomann R; Hofmann E; Rodondi N; Duplain H; Burki D; Mueller B; Christ-Crain M
Trials; 2014 Jun; 15():257. PubMed ID: 24974155
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
